Cargando…
Bilirubin—A Possible Prognostic Mortality Marker for Patients with ECLS
Extracorporeal life support (ECLS) is a promising therapeutic option for patients with refractory cardiogenic shock. However, as the mortality rate still remains high, there is a need for early outcome parameters reflecting therapy success or futility. Therefore, we investigated whether liver enzyme...
Autores principales: | Bunte, Sebastian, Walz, Roland, Merkel, Julia, Torregroza, Carolin, Roth, Sebastian, Lurati Buse, Giovanna, Dalyanoglu, Hannan, Akhyari, Payam, Lichtenberg, Artur, Hollmann, Markus W., Aubin, Hug, Huhn, Ragnar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356548/ https://www.ncbi.nlm.nih.gov/pubmed/32503278 http://dx.doi.org/10.3390/jcm9061727 |
Ejemplares similares
-
Fibrinogen–Albumin-Ratio is an independent predictor of thromboembolic complications in patients undergoing VA-ECMO
por: Roth, Sebastian, et al.
Publicado: (2021) -
Neutrophil-lymphoycyte-ratio, platelet-lymphocyte-ratio and procalcitonin for early assessment of prognosis in patients undergoing VA-ECMO
por: Roth, Sebastian, et al.
Publicado: (2022) -
Perioperative Kardioprotektion – „From bench to bedside“: Aktuelle experimentelle Evidenz und mögliche Gründe für die limitierte Translation in die klinische Praxis
por: Torregroza, Carolin, et al.
Publicado: (2021) -
Risk Factors for Acute Kidney Injury Requiring Renal Replacement Therapy after Orthotopic Heart Transplantation in Patients with Preserved Renal Function
por: M‘Pembele, René, et al.
Publicado: (2021) -
Life impact of VA‐ECMO due to primary graft dysfunction in patients after orthotopic heart transplantation
por: M'Pembele, René, et al.
Publicado: (2021)